|
Market Closed -
NSE India S.E.
07:05:09 2026-08-20 EDT
|
5-day change | 1st Jan Change | ||
| 949.80 INR | +8.06% |
|
+12.38% | +35.26% |
| Market Cap | 7.32B 76.5M 65.5M 61.11M 56.08M 105M 107M 725M 283M 3.67B 287M 281M 12.15B | P/E 2024 |
45.4x | P/E 2025 | 45.4x |
|---|---|---|---|---|---|
| Enterprise Value | 7.28B 76.05M 65.12M 60.76M 55.75M 105M 107M 721M 281M 3.65B 286M 279M 12.07B | EV / Sales 2024 |
4.69x | EV / Sales 2025 | 2.12x |
| Free-Float |
24.75% | Yield 2024 |
0.09% | Yield 2025 | 0.07% |
| 1 day | +8.06% | ||
| 1 week | +12.38% | ||
| Current month | +31.92% | ||
| 1 month | +29.38% | ||
| 3 months | +7.74% | ||
| 6 months | +34.64% | ||
| Current year | +35.26% |
| 1 week | 856 | 967.05 | |
| 1 month | 705 | 967.05 | |
| Current year | 580 | 967.05 | |
| 1 year | 580 | 967.05 | |
| 3 years | 506.25 | 1,417.38 | |
| 5 years | 213.91 | 1,417.38 | |
| 10 years | 213.91 | 1,417.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 38 | 2023-01-15 | |
Bhavik Shah
DFI | Director of Finance/CFO | - | 2026-07-08 |
| Compliance Officer | - | 2023-01-05 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 38 | 2015-09-20 | |
| Chairman | 41 | 2015-09-20 | |
| Director/Board Member | 38 | 2015-09-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +8.06% | +12.38% | +3.31% | +64.78% | 107M | ||
| -2.81% | +2.93% | +76.40% | +126.23% | 1,141B | ||
| -2.21% | +2.02% | +49.50% | +59.77% | 659B | ||
| -1.56% | +4.39% | +25.19% | +74.37% | 470B | ||
| +1.20% | +1.72% | +42.89% | +45.78% | 366B | ||
| -0.61% | +1.72% | +25.21% | +41.34% | 302B | ||
| +0.32% | +3.30% | +2.60% | +13.42% | 254B | ||
| -1.95% | +3.80% | +46.31% | +66.37% | 239B | ||
| -1.10% | -1.12% | -14.91% | -52.66% | 207B | ||
| -2.82% | +3.84% | +20.81% | +88.89% | 183B | ||
| Average | -0.24% | +4.09% | +27.73% | +52.83% | 382.11B | |
| Weighted average by Cap. | -1.34% | +4.31% | +43.81% | +71.26% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.13B 22.25M 19.05M 17.77M 16.31M 30.64M 31.24M 211M 82.18M 1.07B 83.53M 81.71M 3.53B | 6.2B 64.83M 55.51M 51.79M 47.52M 89.3M 91.06M 614M 240M 3.11B 243M 238M 10.29B |
| Net income | 215M 2.25M 1.93M 1.8M 1.65M 3.1M 3.16M 21.33M 8.32M 108M 8.45M 8.27M 357M | 291M 3.04M 2.6M 2.43M 2.23M 4.18M 4.27M 28.79M 11.22M 146M 11.41M 11.16M 482M |
| Net Debt | -178M -1.86M -1.59M -1.49M -1.36M -2.56M -2.61M -17.63M -6.87M -89.2M -6.98M -6.83M -295M | -42.9M -448K -384K -358K -329K -618K -630K -4.25M -1.66M -21.5M -1.68M -1.65M -71.18M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-20 | ₹949.80 | +8.06% | 47,400 |
| 26-08-19 | ₹878.95 | -1.66% | 4,100 |
| 26-08-18 | ₹893.80 | -1.49% | 2,800 |
| 26-08-17 | ₹907.30 | +1.11% | 21,700 |
| 26-08-14 | ₹897.35 | +2.09% | 30,900 |
- Stock Market
- Stocks
- REMUS Stock
Select your edition
All financial news and data tailored to specific country editions
















